Skip to Main Content
SPRIM
  • Consulting
    • Strategy & Innovation
    • Research & Clinical Services
    • Regulatory & Scientific Affairs
    • Medical Marketing & Engagement
  • Ventures
  • News
    • News & Blog
    • Case Studies
    • Publications
  • About
    • Leadership
    • Locations
  • Contact

Publications

back to all Publications
Publication

Prognostic value of liver fibrosis and steatosis biomarkers in type-2 diabetes and dyslipidaemia

Alimentary Pharmacology and Therapeutics, 2014
H. Perazzo, M. Munteanu, Y. Ngo, P. Lebray, N. Seurat, F. Rutka, M. Couteau, S. Jacqueminet P. Giral, D. Monneret, F. Imbert-Bismut, V. Ratziu, A. Hartemann-Huertier, C. Housset, T. Poynard & for the FLIP Consortium
PubMed: 25186086
DOI: 10.1111/apt.12946
Metabolic Disorders, Noninvasive Tests, Diabetes, Dyslipidemia
SPRIM Logo
  • Consulting
    • Strategy & Innovation
    • Research & Clinical Services
    • Regulatory & Scientific Affairs
    • Medical Marketing & Engagement
  • News
    • Case Studies
    • News & Blog
    • Publications
    • Digital & AI
  • About
    • SPRIM Ventures
    • Leadership
    • Locations
    • Our Industries

© 2025 SPRIM. All Rights Reserved

  • Privacy Policy
  • Terms & Conditions
  • Sitemap
  • Contact Us
  • Facebook
  • Linkedin

© 2025 SPRIM. All Rights Reserved